Skip to Main Content
Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

On Location

Updates from major medical meetings in the field of hematology/oncology
RedirecTT-1 Combo of Teclistamab and Talquetamab Suggests Efficacy in R/R MM
Brandon May
GPRC5D-Directed CAR T-Cell Therapy BMS-986393 Shows Potential for R/R MM
Leah Lawrence
MRD-Adapted Treatment Identified Newly Diagnosed Patients with MM for Intensification, Cessation
Leah Lawrence
Efgartigimod Shows Long-Term Safety, Efficacy in Long-Standing Primary ITP
Leah Lawrence
Rusfertide Effectively Supports Hematocrit Control in PV
Brandon May
Non-Chemo Sequential Therapy Achieves High Remission in Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia
Anna Azvolinsky, PhD
MajesTEC-2: Future of BCMA-targeted Bispecific, Gamma Secretase Inhibitor Combo in Question
Brandon May
Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B
Brandon May
Mediastinal Radiotherapy Safe To Omit in PMBCL After Complete Metabolic Response
Leah Lawrence
Recombinant ADAMTS13 Yielded Higher ADAMTS13 Exposure Compared With Plasma Exchange for iTTP
Leah Lawrence
Intrathecal and Intravenous Methotrexate Prophylaxis Show Similar Efficacy for CNS Relapse in High-Risk DLBCL
Brandon May
Combination Therapy for Richter Syndrome Explored
Ruth Jessen Hickman, MD
Epcoritamab Plus Lenalidomide and Rituximab Yields High Response in R/R FL
Katie Robinson
Study Addresses Oncology Clinician Burnout at a Community Cancer Center
Anna Azvolinsky, PhD
Luspatercept Effective for the Treatment of Anemia in Patients with Myelofibrosis
Lara C. Pullen, PhD
CHOP with Anti-CCR4 Antibody Effective for Older Patients with T-Cell Leukemia/Lymphoma
Lara C. Pullen, PhD
Liso-Cel Yields Durable Response in R/R CLL/SLL
Katie Robinson
Phase II Linvoseltamab Study Confirms Efficacy in R/R MM
Katie Robinson
Nivolumab Improves PFS Over Brentuximab Vedotin in Advanced-Stage cHL
Katie Robinson
Results from Combination Trial in Older Adults with Treatment-Naïve CLL Confounded by COVID-Related Deaths
Anna Azvolinsky, PhD
  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright ©2023 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal